New York, NY -- (SBWIRE) -- 03/12/2021 -- This can be mainly associated with the increasing predominance of lifestyle-associated chronic diseases such as diabetes and cancer that serves as an essential contributing factor towards improving drug development and their following commercialization which are expected to drive the market growth. This is supposed to increase the need to study and ensure the safety of targeted and specific therapies, circumvent probable shortcomings and evaluate their outcomes. As a result of high manufacturing effectiveness, pharmaceutical and biotechnology companies are including biological safety testing tools to offer highly effective and contamination-free biologics to provide to the large population experiencing from target diseases.The global Biological Safety Testing Market is expected to reach USD 7.25 billion in 2027.

Key participants include Charles River Laboratories International Inc., SGS SA, Lonza Group, Sigma-Aldrich Corporation, WuXiPharmaTech Inc., Avance Biosciences Inc., BSL Bioservice, Merck KGaA, Cytovance Biologics Inc., and Toxikon Corporation, among others.

To Get Sample Copy of Report visit: https://www.reportsanddata.com/sample-enquiry-form/1412

Biologics are products manufactured from living organisms and has a unique set of features. Safety of biologics and specialized evaluation of the same is of the highest importance. Biological safety testing is essential for new products launching. Biological safety testing is performed to assure a safe quality and non-contamination of vaccines and biopharmaceuticals.

Accelerated growth in biotechnology and pharmaceutical industries, increasing prevalence of chronic diseases, rise in population, rise in R&D investment in life sciences, increasing number of innovative product launches, and increasing government support for biotechnology and pharmaceutical industries are some important factors for the North America region to account for the largest share of 37.3% of the market in 2018.

For the purpose of this study, Reports and Data have segmented the global Biological Safety Testing Market on the basis of Product, Application, Test Type and region:

Product Outlook (Revenue, USD Million; 2016-2026)

Reagents & kits
Instruments
Services

Application Outlook (Revenue, USD Million; 2016-2026)

Vaccines & therapeutics
Stem cell
Tissue & tissue-based products
Gene therapy
Blood & blood-based therapy

Test Type Outlook (Revenue, USD Million; 2016-2026)

Endotoxin tests
Bioburden tests
Adventitious agent detection tests
Residual host contamination detection tests
Sterility tests
Cell line authentication and characterization tests
Others

Regional Outlook (Revenue, USD Million; 2016-2026)

North America
Europe
Asia Pacific
Latin America
MEA

To get a Discount on the Biological Safety Testing Market Report, Click @ https://www.reportsanddata.com/discount-enquiry-form/1412

Further key findings from the report suggest

Due to increasing demand from biological safety testing laboratories, the instruments product segment accounts for a market share of 31.2% in 2018.

Instruments are used to perform bioburden and toxicology tests among the other type of tests.
The increasing demand is due to the growing influence of regulatory bodies to implement safety guidelines by the biopharma companies.

Reagents and kits product segment is estimated to reach USD 2.73 billion by 2026 at a CAGR of 12.1% during the forecast period.

These reagents are attachments and matrix factors, freezing and dissociation reagents, antibiotics, biological buffers, and miscellaneous reagents.

Growing advancements and modifications in the formulation of reagents and kits will encourage laboratory technicians in including these products, specifically in toxicology assessment.

The increased demand for vaccine and therapeutic segment is due to clearly defined guidelines ensuring the safety of developed vaccines along with the unaltered therapeutic value and decreased toxicity.
Regulatory organizations are working towards implementing relevant standards for biological safety to ensure the patient's safety.

Vaccine and therapeutic application is estimated to reach USD 2.62 billion by 2026.

Endotoxin tests type accounted for the largest share of 27.6% of the market in 2018.

The abundant share is due to the increasing incorporation of these tests in an extensive range of areas of drug manufacturing to decrease the threat of endotoxins during the biopharmaceutical manufacture.

Also, availability of various types of endotoxin tests, such as turbidimetric method, gel clot endotoxin testing, and USP chromogenic endotoxin testing, which are intended to suit different requirements, are expected to boost the growth of this segment…Continued

Browse Full Report @ https://www.reportsanddata.com/report-detail/biological-safety-testing-market

Table of Content –

Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018-2026
Chapter 3. Indicative Metrics
Chapter 4. Biological Safety Testing Market Segmentation & Impact Analysis
4.1. Biological Safety Testing Market Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Rising number of biological and pharmaceutical industries
4.2.2.2. Growing R&D investments by government
4.2.3. Market restraints analysis

Continued…

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/1412

Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs. 

Similar Reports –

Antiseptics and Disinfectants Market Size

Biological Seed Treatment Market Share

Downstream Processing Market Growth

Phosphate Rock Market Outlook

Controlled-Release Fertilizers Market Demand

About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:
John W
Head of Business Development
40 Wall St. 28th floor New York City
NY 10005 United States
Direct Line: +1-212-710-1370